GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Response Oncology Inc (GREY:ROIX) » Definitions » Debt-to-Equity

Response Oncology (Response Oncology) Debt-to-Equity : 0.00 (As of Mar. 2002)


View and export this data going back to 1989. Start your Free Trial

What is Response Oncology Debt-to-Equity?

Response Oncology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2002 was $0.0 Mil. Response Oncology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2002 was $0.0 Mil. Response Oncology's Total Stockholders Equity for the quarter that ended in Mar. 2002 was $-18.9 Mil. Response Oncology's debt to equity for the quarter that ended in Mar. 2002 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Response Oncology's Debt-to-Equity or its related term are showing as below:

ROIX's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Debt-to-Equity only.

Response Oncology Debt-to-Equity Historical Data

The historical data trend for Response Oncology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Response Oncology Debt-to-Equity Chart

Response Oncology Annual Data
Trend Dec92 Dec93 Dec94 Dec95 Dec96 Dec97 Dec98 Dec99 Dec00 Dec01
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.91 0.84 1.05 -

Response Oncology Quarterly Data
Jun97 Sep97 Dec97 Mar98 Jun98 Sep98 Dec98 Mar99 Jun99 Sep99 Dec99 Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.93 1.50 - -

Competitive Comparison of Response Oncology's Debt-to-Equity

For the Medical Care Facilities subindustry, Response Oncology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Response Oncology's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Response Oncology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Response Oncology's Debt-to-Equity falls into.



Response Oncology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Response Oncology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2001 is calculated as

Response Oncology's Debt to Equity Ratio for the quarter that ended in Mar. 2002 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Response Oncology  (GREY:ROIX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Response Oncology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Response Oncology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Response Oncology (Response Oncology) Business Description

Traded in Other Exchanges
N/A
Address
1775 Moriah Woods Boulevard, Memphis, TN, USA, 38117
Website
Response Oncology Inc provides cancer treatments and related services on an outpatient basis.

Response Oncology (Response Oncology) Headlines

No Headlines